Philosophy of Care
The mission of Dr. Raslan's is to provide the highest quality patient-centered care, while contniously advancing patient care through novel cutting edge research.
Dr.Raslan has clinical interests in neuroradiology, focusing on advanced magnetic resonance imaging techniques of brain tumors.
His research interests also includes head and neck imaging as well as nuclear and molecular neuroimaging.
In addition, Dr. Raslan has a strong interest in radiology education.
Dr. Raslan's research focuses on the advanced neuroimaging techniques, espsially the role of magnetic resonance imaging in the early detection, preoprative surgical planning and post treatment care of patiens with brain tumors.
Dr. Raslan also have strong interest in nuclear neuroimaging as well as radiology education.
M.B.B.Ch., Cairo University, Cairo, Egypt 1999
M.Sc., Diagnostic Radiology, Cairo University, Cairo, Egypt 2004
Diagnostic Radiology, National Cancer Institute, Cairo, Egypt 2001-2004
Nuclear Medicine, St. Louis University, St. Louis MO 2012-2015
Neuroradiology, Loyola University Medical Center, Chicago IL 2016-2017
PET/CT, St. Louis University, St. Louis MO 2015-2016
Interventional Radiology, University of Alabama, Birmingham AL 2010-2011
Neuroradiology, University of Massachusetts, Worcester MA 2011-2012
American Board of Nuclear Medicine, 2015
American Board of Radiology, 2016
American Society of Neuroradiology
Radiological Society of North America
Society of Nuclear Medicine and Molecular Imaging
Honors and Awards
MAGIS Star Recognition, Loyola University Medical Center, 2017
MAGIS Star Recognition, Loyola University Medical Center, 2016
RSNA Press Release, 2014: PET/CT Shows Pituitary Abnormalities in Veterans with PTSD, 2014
?RSNA On-the-Air? Radio show, RSNA 2014. Estimated audience 43,800, 2014
?Young Professionals Committee (YPC) Award? (3rd place), SNMMI, 2014, 2014
Select Recent Publications
Raslan OA, Parkar ND, Muzaffar R, Doherty C, Osman MM. Case 227: Endobronchial Carcinoid Tumor with Incidental Metastatic Breast Cancer Detected with Somatostatin Receptor Scintigraphy ((111)In Pentreotide). Radiology. 2016 Mar; 278(3): 949-55.
Raslan OA, Muzaffar R, Shetty V, Osman MM. Image findings of cranial nerve pathology on [18F]-2- deoxy-D-glucose (FDG) positron emission tomography with computerized tomography (PET/CT): a pictorial essay. Cancer Imaging. 2015 Dec 3;15:20.
Fatma Ahmed, Osama Raslan, Razi Muzaffar, Nadeem Parkar, Nitin Marwaha, Medhat Osman. Sjogren syndrome complicated by mucosa-associated lymphoid tissue lymphoma and lymphocytic interstitial pneumonia. Front Oncol. 2015 Aug 06; 5:179. eCollection 2015.
Muzaffar R, Raslan O, Osman MM. 18F-FDG-avid plantar nodules on true whole-body 18F-FDG PET/CT in cancer patients. Nucl Med Commun. 2015, Sep;36(9):881-6.
Raslan O, Debnam JM, Ketonen L, Kumar AJ, Schellingerhout D, Wang J. Stereoscopic visualization of diffusion tensor imaging data: a comparative survey of visualization techniques. Radiol Res Pract. 2013;2013:780916. Epub 2013 Oct 22.
Raslan OA, Schellingerhout D, Fuller GN, Ketonen LM. Rosai-Dorfman disease in neuroradiology: imaging findings in a series of 10 patients. AJR Am J Roentgenol. 2011 Feb;196(2):W187-93.
Gayed IW, Raslan OA, Bhosale PR, Perrier ND, Wei W, Gladish G. Significant coronary calcification detected using contrast-enhanced computed tomography: is it an indication for further investigation? Clin Nucl Med. 2010 Jun;35(6):404-8.
Raslan O, Ketonen LM, Fuller GN, Schellingerhout D. Intracranial Rosai-Dorfman disease with relapsing spinal lesions. J Clin Oncol. 2008 Jun 20;26(18):3087-9.
R. Muzaffar, O. Raslan, M. Osman. (2014). Nuclear Oncology 2. In A. Elgazzar (Ed.). The Pathophysiologic Basis of Nuclear Medicine. (p.369-400). Third edition. New York: Springer.
Raslan O, Ketonen LM, Fuller GN, Schellingerhout D. (2010). Central Nervous System Rosai Dorfman Disease. In M. A.Hayat (Ed.), Methods of Cancer Diagnosis, Therapy and Prognosis Methods of Cancer Diagnosis, Therapy and Prognosis Volume 8. (p. 365-375). New York, NY. Springer.